DIgital Alcohol Management ON Demand (DIAMOND) feasibility randomised controlled trial of a web-based intervention to reduce alcohol consumption in people with hazardous and harmful use versus a face-to-face intervention: protocol by Hamilton, FL et al.
Hamilton et al. Pilot and Feasibility Studies  (2015) 1:28 
DOI 10.1186/s40814-015-0023-1STUDY PROTOCOL Open AccessDIgital Alcohol Management ON Demand
(DIAMOND) feasibility randomised
controlled trial of a web-based intervention
to reduce alcohol consumption in people
with hazardous and harmful use versus a
face-to-face intervention: protocol
Fiona L. Hamilton1*, Jo Hornby1, Jessica Sheringham2, Sally Kerry3, Stuart Linke4, Francesca Solmi2,
Charlotte Ashton5, Kevin Moore6 and Elizabeth Murray1Abstract
Background: “Hazardous and harmful” drinkers make up approximately 23 % of the adult population in England.
However, only around 10 % of these people access specialist care, such as face-to-face extended brief treatment in
community alcohol services. This may be due to stigma, difficulty accessing services during working hours, a shortage
of trained counsellors and limited provision of services in many places. Web-based alcohol treatment programmes
may overcome these barriers and may better suit people who are reluctant or unable to attend face-to-face services,
but there is a gap in the evidence base for the acceptability, effectiveness and cost-effectiveness of these
programmes compared with treatment as usual (TAU) in community alcohol services.
This study aims investigate the feasibility of all parts of a randomised controlled trial (RCT) of a psychologically
informed web-based alcohol treatment programme called Healthy Living for People who use Alcohol (HeLP-Alcohol)
versus TAU in community alcohol services, e.g. recruitment and retention, online data collection methods, and
the use and acceptability of the intervention to participants.
Methods: A feasibility RCT delivered in north London community alcohol services, comparing HeLP-Alcohol with TAU.
Potential participants are aged ≥18 years referred or self-referred for hazardous and harmful use of alcohol, without
co-morbidities or other complex problems. The main purpose of this study is to demonstrate the feasibility of recruiting
participants to the study and will test online methods for collecting baseline demographic and outcome questionnaire
data, randomising participants and collecting 3-month follow-up data. The acceptability of this intervention will be
measured by recruitment and retention rates, automated log-in data collection and an online service satisfaction
questionnaire. The feasibility of using tailored text message, email or phone prompt to maintain engagement with the
intervention will also be explored. Results of the study will inform a definitive Phase 3 RCT.
Results: Recruitment started on 26 September 2014 and will run for 1 year.
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Conclusion: The proposed trial will provide data to inform a fully powered non-inferiority effectiveness and
cost-effectiveness RCT comparing HeLP-Alcohol with TAU.
Trial registration: ISRCTN31789096.
Keywords: Alcohol, Brief intervention, Digital intervention, Randomised controlled trialBackground
Alcohol is the second biggest lifestyle risk factor for
disease and premature mortality after smoking [1]. Al-
cohol misuse is estimated to cost the UK around £21
billion per year [2, 3]. This includes National Health
Service (NHS) costs for treating accidents, assaults result-
ing from alcohol intoxication, conditions such as liver dis-
ease, cardiovascular disease and cancers, and the cost of
alcohol treatment services. Societal costs include those as-
sociated with absenteeism, unemployment, family break-
down, road traffic collisions and crime.
These costs are mainly due to the large number of
“hazardous and harmful” drinkers who make up ap-
proximately 23 % of the adult population; about 7.1 mil-
lion people in England [4]. Hazardous drinkers are those
whose alcohol intake is greater than government recom-
mended limits (14 units a week for women and 21 units
for men; or 2–3 units daily for women and 3–4 units for
men). Harmful drinkers are those drinking more than
recommended limits, and experiencing alcohol-related
harm, but without symptoms of physical or psycho-
logical dependence. About 3.6 % of the population (1.1
million) people in England are dependent on alcohol.
People drinking at hazardous or harmful levels can
respond well to a tiered approach to treatment [5]. Tier
1 is identification and brief advice (IBA), also known as
screening and brief intervention (SBI). This may be
conducted by a health professional in any setting, for
example general practice or accident and emergency
department (A&E). Identification is through the use of
validated questionnaires such as the Alcohol Use Disorders
Identification Test (AUDIT) [6], or shortened versions of
AUDIT such as AUDIT Consumption (AUDIT-C) [7] or
the Fast Alcohol Screening Test (FAST) [8]. Brief advice
involves a short conversation about the risks of alcohol use
at the current level, advice on reducing drinking levels and
sources of self-help, usually supplemented with a leaflet
[9]. Tier 2/3 treatments are provided at community alcohol
drug and alcohol services, which offer more specialised
treatment for people who need more than IBA, including
extended brief intervention face-to-face, either indi-
vidually or in groups, and complimentary therapies tai-
lored to the individual. Tier 4 is detoxification and
other treatment targeted at dependent drinkers with
significant co-morbidities such as liver disease, severe
mental health problems or multiple substance misuse.IBA for hazardous and harmful drinking results in a
significant and sustained reduction in alcohol consump-
tion, which has been quantified in a meta-analysis by
Kaner et al. [10] as a mean difference of −38 g of alcohol
a week (CI −53 to −23 g) compared with control treat-
ments. This translates to a reduction in average weekly
intake of around four standard UK drinks (1 unit = 8 g
alcohol). IBA is also likely to be cost-saving [11]. Despite
this, not everyone who drinks at hazardous or harmful
levels will find IBA sufficient to help them reduce their
drinking and will need to access Tier 2/3 services.
There are enormous challenges in meeting demand for
Tier 2/3 services, and estimates suggest only 6 to 10 % of
people with problem alcohol use are accessing specialist
treatment in England [4, 12]. Over the last several years
commissioners of drug and alcohol services have faced a
funding deficit [13]. This has inevitably resulted in a short-
age of trained alcohol counsellors, with skills over and
above the generic competencies that all primary care and
A&E health care professionals need to provide IBA. In
addition, hazardous or harmful alcohol use is recognised
to be a relapsing and remitting condition so patients may
need to access help repeatedly. Even if services are avail-
able, people may be reluctant to attend due to perceived
stigma of having alcohol problems, or they may work and
so cannot attend during working hours.
Online interventions could address these challenges.
Internet use is widespread: 84 % of households in Great
Britain having access to the internet, 76 % of adults use
the internet every day and 58 % use a mobile phone to
do so [14]. Online interventions are relatively inexpen-
sive to set up, are convenient to access and provide ano-
nymity, which is important to people with stigmatising
conditions. A recent systematic review has shown that
online interventions may be effective and cost-effective
in treating hazardous and harmful alcohol use [15]. The
feasibility of providing online interventions similar to
Tier 2/3 community alcohol services has been demon-
strated and also found to be acceptable to alcohol coun-
sellors [16]. However, much of the research to date has
looked at online interventions for IBA, largely in stu-
dent populations. There are relatively few data demon-
strating the effectiveness of extended brief intervention
in adult populations of hazardous and harmful drinkers,
and no data comparing face-to-face treatment with
online treatment.
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(RCT) could address these gaps in knowledge, but there
are recognised challenges with trials of web-based inter-
ventions, hence we propose to undertake a feasibility
RCT first. The challenges include low engagement rates
and attrition (non-use or fall-off in engagement with the
intervention [17]), which limit their effectiveness, and
high dropout rates (e.g. failure to complete follow-up
questionnaires) seen in online trials [18]. There is also
the potential for widening the digital divide, leading to
health inequalities, as people from more deprived groups
are less likely to have access to the internet and older
people may have limitations in readiness and capacity to
use online technologies [19, 20]. In light of these chal-
lenges, we feel that a feasibility study is required prior to
applying for funding to carry out a Phase 3 RCT de-
signed to test the hypothesis that supported access to an
online alcohol intervention which mirrors treatment in
community alcohol services is as effective, and more
cost-effective, than traditional face to face treatments.
Aims of the trial
The overall aim of this study is to determine the feasibil-
ity of conducting a RCT comparing supported access to
a web-based Tier 2/3 treatment called Healthy Living for
People who use Alcohol (HeLP-Alcohol) with usual care
(face-to-face treatment in community alcohol services).
The feasibility study will determine recruitment and
retention rates and acceptability of the intervention; will
test the online randomisation and data collection instru-
ments at baseline and at 3 months; and will test methods
to promote participant engagement with the interven-
tion. We will also estimate health professional time
involved in facilitating both arms of the trial. The out-
comes of this feasibility study will inform a fully powered
Phase 3 randomised controlled effectiveness trial and an
economic evaluation.
Methods
Design
This is a randomised controlled feasibility trial.
Setting
The London boroughs of Camden, Islington and Haringey
have agreed to participate in the study, and we have re-
cruited four community alcohol services to take part.
Teams will be trained in good clinical practice (including
trial paperwork, confidentiality, data management/clinical
governance) and supported in recruiting and consenting
participants.
Population
We will recruit hazardous and harmful drinkers, identi-
fied using a validated screening tool such as AUDIT andreferred from primary care, secondary care or self-
referred, to community alcohol services.
 Inclusion criteria: patients are eligible to take part in
the trial if they are aged 18 or over at time of
screening; have a diagnosis of an alcohol use
disorder using AUDIT criteria (score 8 or over);
have a stable place of residence; provide informed
consent for randomisation, treatment and follow-up;
are willing and able to use a computer to access an
online alcohol treatment programme.
 Exclusion criteria: patients are excluded from the
trial if they have undergone treatment for
substance use or primary drug dependence
(excluding nicotine) in the previous 90 days; are
already receiving help for an alcohol use disorder;
have outstanding legal issues likely to lead to
imprisonment; have severe physical dependency
on alcohol (Leeds Dependence Questionnaire >20)
or severe and complex co-existing physical or
mental health problems, or are at risk of self-harm
or suicide; are unable to consult in English
without an interpreter; or if they are pregnant. If
alcohol counsellors have concerns about a client
regarding child protection issues or domestic
violence, they will also be excluded. Patients
without prior internet experience or without home
access to the internet will not be excluded, but will
be offered additional training as part of their
facilitated access to the web-based alcohol
treatment programme. All participants will be
given information about local free or low-cost
public internet access points, such as libraries,
health centres and cluster rooms and local sources
of support.
Intervention
Supported access to HeLP-Alcohol, a modular, web-
based alcohol treatment programme for people who
drink at hazardous and harmful levels but who are not
dependent on alcohol. HeLP-Alcohol is designed to be
used over a 6-week period and has three evidence-
based phases based on Motivational Interviewing,
Computerised Cognitive Behavioural Therapy, and
Relapse Prevention. Users can set up tailored text mes-
sage or email prompts to help them achieve their
drinking goals. Participants will also receive a weekly
text message, email or phone call to encourage use of
the website.Comparator
Treatment as usual (TAU) at participating community
alcohol services.
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Clients will attend their assessment appointment with an
alcohol counsellor as usual. If the alcohol counsellor
considers the client meets the inclusion criteria for the
trial (detailed above) they will discuss the trial with the
client and provide written information and ask them to
sign the consent form if they express interest in taking
part. The client will be given a 24-hour “cooling off”
period to decide whether or not to proceed.
Data collection
If the client wishes to participate, they will be allo-
cated a trial identification number linked to their
email address and mobile phone number. All data will
be collected anonymously online. All participants will
be emailed a link to complete the baseline data collec-
tion questionnaires (see outcome measures, below).
After they have completed the questionnaires, they
will then be individually randomised by computer to
the intervention or TAU. Those randomised to the
intervention will be emailed a link to HeLP-Alcohol
and those randomised to TAU will be directed back to
their community alcohol service. All participants will
be emailed another request for follow-up data collec-
tion 3 months after randomisation. For those partici-
pants who do not respond to the first email, there will
be another two follow-up emails and then a phone call
or text message request. See Fig. 1 for CONSORT
participant flow diagram [21].
Outcome measures
Primary outcomes
1. Recruitment as a percentage of eligible patients.
2. Retention measured by completeness of online data
collection for each arm at baseline and at 3 months
as a percentage of patients randomised.
Secondary outcomes
3. Demographic characteristics of participants recruited
to each arm: age, sex, ethnic group, highest
educational attainment and area deprivation
(measured by Index of Multiple Deprivation) will be
recorded at baseline, which will enable us to determine
if there are inequalities in retention and use of the
online intervention (for those randomised to this arm).
4. Outcome measures to be collected at baseline and at
3 months will include:
(a) Unit consumption of alcohol per week (using
TOT-AL, an online beverage-specific measure
[22] which requires participants to enter the type
and quantity of alcohol drinks consumed on each
day of the past week)(b) Alcohol Use Disorders Identification Test
(AUDIT) score [6], a method of screening for
excessive drinking, developed by the World
Health Organization (WHO) for use across a
range of health settings
(c) Current psychological global distress score (using
CORE-10 [23] developed and validated as a non-
proprietary measure of psychological distress)
(d) Well-being scores (using EQ-5D [24])
(e) Self-efficacy (using SCQ-8 [25]).
5. Outcome measures to be collected at 3 months:
(a) Adherence to the intervention (for those
randomised to this arm), measured through
automated recording of numbers of log-ins and
numbers of pages visited at each log-in
(b) Other sources of support accessed during
treatment (e.g. group therapy; horticulture;
acupuncture; art therapy; other therapies)
(c) Participant satisfaction with care (measured using
the 8-item Client Satisfaction Questionnaire
(CSQ-8), developed as a measure of satisfaction
for mental health services, [26, 27] and used for
assessing satisfaction with alcohol and other
substance misuse programme) [28].
Sample size
As this is a feasibility study a formal sample size calcu-
lation is not required, but we estimated the number of
participants required as around 10 % of the number
required for the Phase 3 trial [29]. The sample size
calculation for the Phase 3 trial suggests we need to
recruit 1665 participants. Given the participant popu-
lation, a high level of attrition may be anticipated. We
therefore aim to recruit 200 participants to the feasi-
bility trial to inform the design and sample size of the
Phase 3 RCT.
Data handling and record keeping
Data from the website will be saved to a trial database
which complies with the requirements of Good Clinical
Practice and is maintained by the website developer.
Data will be exported for analysis via UCL’s Identifiable
Data Handling Solution (IDHS), which utilises a secure
link to a secure drop box using ID numbers only and
no identifying information. Participant contact details
will be kept in a locked filing cabinet on university
premises. Participant information at trial sites will also
be kept securely according to local policies. The project
has been registered with the UCL Data Protection Officer
according to UCL Data Protection Policy.
Statistical analysis
As this is a feasibility RCT, no hypothesis is to be tested.
The aim of the trial is to determine estimates of
No
No
Completed follow up online data 
Randomisation
Hazardous or harmful drinkers, identified by screening test, through primary or secondary care or 
self-administered, e.g. online, agreeing to be referred, or self-referred to community alcohol services
Full assessment at first appointment as per usual practice
Facilitated access to HeLp -Alcohol + tailored 
email/text message prompts + phone calls/text 
messages to encourage engagement
Usual community alcohol service treatment for 
hazardous and harmful drinking 
Completed online baseline data 
collection
Participant excluded and 
treated according to local 
guidelines (
Other (reason) 
Participant met inclusion criteria
Analysed
Excluded from analysis
Analysed
Excluded from analysis
No
Completed follow up online data collection 
Lost to follow up 
Fig. 1 CONSORT participant flow diagram
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of the intervention and to provide parameters for the
power calculation for a Phase 3 trial. Success criteria for re-
cruitment and retention will be 84 and 75 %, respectively,
as per the UKATT trial [30].
The analysis will be mainly descriptive. Descriptive sta-
tistics will be used to compare demographic characteristics
of those completing each arm of the trial with those lost
to follow-up. We will use multivariate logistic regression
with robust confidence intervals (CI) to examine the im-
pact of age, gender, ethnicity and deprivation level on
these outcomes.
We will perform an analysis using regression of out-
come on randomised group, adjusted for baseline
value of outcome (for those outcomes measured at
baseline) and other variables (age, gender, ethnicityand deprivation level) to compare the two arms using
the following outcome measures at 3 months. Differ-
ences between the intervention and control groups for
continuous variables with skewed distribution, e.g. alcohol
consumption, will be log transformed, following a similar
analysis to that by Wallace et al. [31]:
 Change in mean unit consumption of alcohol
per week;
 Change in AUDIT score;
 Change in level of current psychological global
distress score;
 Change in self-efficacy score;
 Acceptability of intervention using CSQ-8;
 Use of additional sources of support accessed during
the trial period.
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ence to the intervention, measured through automated
recording of numbers of log-ins and numbers of pages
visited at each log-in. We will conduct within-group
analysis using linear regression to examine the impact
of age, gender, ethnicity and deprivation on use of the
intervention (number of log-ins, number of pages
accessed, number of modules completed).
Missing data will be handled as follows:
 The primary analysis will be the mean difference in
changes from baseline in all outcome variables
between intervention and control groups at
3 months, using all available results but without
imputation of missing data. Secondary analyses will
include all randomised individuals by assuming that
non-responders have no change in any missing
outcome measures;
 For use of the intervention, data will be largely
complete as automatically collected by the website.
Trial status
We started recruiting patients to the trial in September
2014. Recruitment will run for 1 year, with data collection
complete by end-December 2015.
Discussion
Hazardous and harmful alcohol use is a growing prob-
lem in the UK. Face-to-face treatment is only accessed
by around 10 % of those who could benefit, for several
reasons, of which the most important are lack of
provision, stigma and inconvenience. We have devel-
oped a psychologically informed web-based alcohol
programme which may help fill this gap in access, but
its effectiveness, cost-effectiveness and equality of ac-
cess compared with usual treatment in community
alcohol services need to be ascertained in a fully pow-
ered RCT. The results of this feasibility RCT will pro-
vide useful evidence for commissioners of alcohol
services as previous studies of web-based treatments for
hazardous and harmful alcohol use have been con-
ducted mainly online, for example, comparing websites
with and without interaction or feedback [31].
Conducting a Phase 3 RCT to compare a web-based
alcohol treatment programme with face-to-face com-
munity alcohol treatment is likely to face challenges,
hence the need for the feasibility study. Recruitment
and retention rates in the feasibility RCT will give an
indication of the acceptability of the trial to patients
with problem alcohol use. Other methods such as
qualitative interviews may give a better idea of accept-
ability or otherwise, both of the trial and the interven-
tion, and we aim to undertake a separate qualitative
study with participants and alcohol counsellors in duecourse. However, it may not be possible to get the views
of people who decline to participate in the trial as they
are likely to decline to take part in a qualitative study
as well. It is also not possible to determine the charac-
teristics of those who decline to take part as we are not
able to collect their demographic data if they have not
consented to be in the study. However, we will have
access to summary data for all clients seen by a service
as the services collect this data for their own evalua-
tions, so this may give us some indication of the char-
acteristics of those who decline to participate compared
with those who consent.
It may be that potentially eligible clients do not wish
to participate in a trial where there is a chance of being
randomised to a website when they may have a prefer-
ence for face-to-face counselling, or they may not have
easy access to a computer, or feel confident using a com-
puter. If they mention a reason for not participating
when their alcohol counsellor discusses the trial with
them, then we may pick this up from the qualitative
interviews with counsellors.
Alcohol counsellors themselves may not find it ac-
ceptable to recruit people to a trial where they have a
50 % chance of being randomised to a website. The
counsellors may only ask people who they think will be
computer-literate, or may not ask those who they worry
might disengage with the service if they are not seen
face-to-face (selection bias). There may be other rea-
sons why counsellors do not recruit potential recruits
which may come out in the interviews, including time
pressures and competing priorities.
We chose community alcohol services to as a recruit-
ment setting because we expected that our target popu-
lation would present to these services in sufficient
numbers. However, as we are excluding hazardous or
harmful drinkers who have co-morbidities or complex
problems such as other substance misuse, eligible clients
may not in fact present in sufficient numbers to recruit
successfully from this setting.
As previously discussed, attrition from online pro-
grammes and online trials is a common problem [17].
We hope to overcome this using text message, email
and telephone prompts as previous studies suggests such
prompts can improve engagement [32]. We will also col-
lect data on other sources of help accessed during the
study, participants’ satisfaction with the intervention and
estimates of health professional time for each arm,
which will inform the main trial.
The proposed feasibility study is therefore important
in order to identify these challenges prior to designing
the Phase 3 trial, to test online data collection, random-
isation methods and the prompts to encourage contin-
ued use of the intervention. Data from this study will
also be used to refine the sample size calculation for
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cess to HeLP-Alcohol is of equal effectiveness as TAU.
The RCT will be designed to have 90 % power to detect
(at a 5 % significance level) a difference in mean weekly
alcohol consumption of 15 % between intervention and
TAU groups (if such a difference occurs). The assump-
tions are (i) standard deviation of alcohol consumption
at follow-up is equal to 85 % of the mean and (ii) a cor-
relation between baseline and follow-up alcohol con-
sumption of 0.40, as found in a previous RCT of an
online alcohol intervention [30]; (iii) a follow-up rate of
75 % at 12 months, based on the experience of UKATT
[33]; (iv) an intra-cluster correlation of 0.02 for the ef-
fect of alcohol counsellors, also based on the UKATT
trial. The standard error of the mean difference in alco-
hol consumption will be about 5 %, so an estimated
zero difference would have a 95 % confidence interval
of −10 to +10 %. The definitive trial therefore requires
1665 participants.
If the definitive study shows that a web-based alcohol
treatment programme is as effective as face to face treat-
ment, then implementation of such a programme could
increase patient choice, improve access to alcohol treat-
ment for hazardous and harmful drinkers and lead to
cost savings for treatment services and more widely for
the NHS in treating alcohol-related health conditions,
particularly for people who are reluctant or unable to
attend face-to-face services.
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